— Know what they know.
/
Not Investment Advice

OCUL NASDAQ

Ocular Therapeutix, Inc.
1W: +1.1% 1M: -12.3% 3M: -19.6% YTD: -43.1% 1Y: -41.5% 3Y: +186.0% 5Y: -41.5%
$6.72
+0.25 (+3.86%)
 
Weekly Expected Move ±13.0%
$5 $6 $6 $7 $8
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 24 · $1.5B mcap · 185M float · 1.58% daily turnover · Short 55% of daily vol
Credit Risk of going bust: higher than 54% of companies Debt: 5.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.05 (down 99.2%), Ocular Therapeutix, Inc. would be worth roughly what it owes.
Total debt $79.4M against a stock market value of $1.48B.
Distance to default 4.76 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $39.5M (short-term plus half of long-term), stock volatility 73.9%; Altman Z'' 0.09. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
33.0 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -31671.3%  ·  5Y Avg: -6292.4%
Cost Advantage
38
Intangibles
30
Switching Cost
30
Network Effect
47
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. OCUL has No discernible competitive edge (33.0/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. Negative ROIC of -31671.3% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$14
Low
$14
Avg Target
$14
High
Based on 1 analyst since Aug 3, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 16Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$14.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-11 UBS — Initiated $14 — +85.7% $7.54
2026-06-18 H.C. Wainwright — $21 $25 +4 +164.8% $9.44
2026-06-18 Robert W. Baird — $24 $30 +6 +211.2% $9.64
2026-02-05 RBC Capital Lisa Walter Initiated $30 — +222.8% $9.29
2025-12-08 H.C. Wainwright — $19 $21 +2 +66.9% $12.58
2025-10-08 H.C. Wainwright — $14 $19 +5 +64.9% $11.52
2025-10-03 Piper Sandler — $15 $31 +16 +180.3% $11.06
2025-10-03 Robert W. Baird Colleen Kusy $17 $24 +7 +117.0% $11.06
2025-10-01 JMP Securities Jonathan Wolleben $19 $29 +10 +148.1% $11.69
2025-03-04 JMP Securities — $24 $19 -5 +192.3% $6.50
2024-08-08 Robert W. Baird Colleen Kusy Initiated $17 — +103.1% $8.37
2024-06-27 Piper Sandler Biren Amin $10 $15 +5 +123.5% $6.71
2024-06-14 H.C. Wainwright Yi Chen Initiated $14 — +137.8% $5.89
2024-03-11 JMP Securities Jonathan Wolleben Initiated $24 — +158.3% $9.29
2022-06-07 Piper Sandler Joseph Catanzaro Initiated $10 — +164.6% $3.78

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
Oct 27, 2026
DCF
1
ROE
1
ROA
1
D/E
3
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. OCUL receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-02-10 D+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 31 Grade D
Profitability
20
Balance Sheet
30
Earnings Quality
35
Growth
26
Value
36
Momentum
30
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. OCUL scores highest in Safety (100/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
5.72
Safe Zone
Piotroski F-Score
3/9
✗ ✗ ✗ ✓ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
-3.02
Unlikely Manipulator
Ohlson O-Score
-5.18
Bankruptcy prob: 0.6%
Low Risk
Credit Rating
BBB+
Score: 64.6/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.79x
Accruals: -11.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. OCUL scores 5.72, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. OCUL scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. OCUL's score of -3.02 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. OCUL's implied 0.6% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. OCUL receives an estimated rating of BBB+ (score: 64.6/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-4.73x
PEG
0.42x
P/S
28.35x
P/B
2.91x
P/FCF
-8.66x
P/OCF
—
EV/EBITDA
-5.94x
EV/Revenue
32.46x
EV/EBIT
-5.83x
EV/FCF
-6.62x
Earnings Yield
-13.65%
FCF Yield
-11.55%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. OCUL currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.039
EBT / EBIT
×
EBIT Margin
-5.572
EBIT / Rev
×
Asset Turnover
0.093
Rev / Assets
×
Equity Multiplier
1.359
Assets / Equity
=
ROE
-73.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. OCUL's ROE of -73.0% is driven by Asset Turnover (0.093), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$6.72
Median 1Y
$5.28
5th Pctile
$1.47
95th Pctile
$19.06
Ann. Volatility
78.7%
Analyst Target
$14.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Pravin U. Dugel,
M.D. Executive Chair, President and Chief Executive Officer
 $819,200 $18,608,000 $35,946,958
Nadia Waheed, M.D.
Chief Medical Officer
 $536,667 $1,091,490 $4,378,925
Donald Notman Operating
rating Officer and Chief Financial Officer
 $560,175 $855,600 $3,670,959
Sanjay Nayak, M.B.B.S.,
Ph.D. Chief Strategy Officer
 $510,000 $825,840 $3,463,405
Steve Meyers Commercial
ercial Officer
 $510,000 $550,560 $2,550,269

CEO Pay Ratio

99:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $35,946,958
Avg Employee Cost (SGA/emp): $363,994
Employees: 325

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
325
+18.6% YoY
Revenue / Employee
$159,455
Rev: $51,823,000
Profit / Employee
$-818,274
NI: $-265,939,000
SGA / Employee
$363,994
Avg labor cost proxy
R&D / Employee
$606,449
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -2.1% -8.0% -27.2% -44.5% -88.9% -1.2% -2.0% -2.6% -2.5% -1.3% -55.2% -72.7% -96.9% -95.2% -57.2% -63.4% -81.8% -54.9% -68.6% -73.0% -72.99%
ROA -55.9% -2.8% -10.3% -16.1% -31.5% -40.1% -56.2% -61.4% -41.8% -40.2% -34.5% -43.3% -53.4% -54.5% -40.8% -44.8% -55.4% -42.0% -51.0% -53.7% -53.70%
ROIC 1.8% 3.6% 9.3% 6.4% 4.1% 23.6% 14.0% -53.1% 3.3% 3.1% 144.5% 12.7% 1487.9% 139.2% 21.4% 21.8% 20.8% 71.9% 41.8% -316.7% -316.71%
ROCE -42.4% 0.1% -9.5% -17.5% -40.6% -54.3% -82.6% -92.4% -45.6% -32.0% -19.8% -25.4% -35.2% -43.2% -49.0% -50.1% -65.7% -33.6% -40.7% -46.6% -46.62%
Gross Margin 89.2% 91.0% 90.1% 90.6% 91.0% 92.8% 90.9% 91.4% 90.9% 90.6% 91.0% 90.8% 89.9% 92.8% 88.2% 85.6% 87.8% 88.0% 87.7% 85.1% 85.08%
Operating Margin -1.6% -1.5% -1.4% -1.6% -1.8% -1.4% -1.7% -1.4% -1.3% -1.4% -2.1% -2.7% -3.0% -3.0% -6.0% -5.0% -4.7% -5.3% -8.7% -6.1% -6.09%
Net Margin 21.9% -31.3% -95.1% -1.5% -2.0% -1.1% -2.3% -1.4% -3.4% -2.0% -4.4% -2.7% -2.4% -2.8% -6.0% -5.0% -4.8% -4.9% -8.2% -5.8% -5.85%
EBITDA Margin 40.4% -13.0% -78.1% -1.3% -1.8% -93.8% -2.1% -1.2% 25.2% -1.6% -4.1% -2.4% -2.1% -2.6% -5.6% -4.7% -4.5% -4.6% -7.8% -5.5% -5.50%
FCF Margin -1.5% -1.5% -1.4% -1.2% -1.2% -1.2% -1.3% -1.4% -1.3% -1.4% -1.5% -1.6% -1.9% -2.1% -2.5% -3.2% -3.6% -4.2% -4.6% -4.9% -4.90%
OCF Margin -1.5% -1.5% -1.4% -1.2% -1.2% -1.2% -1.2% -1.3% -1.2% -1.3% -1.5% -1.5% -1.9% -2.1% -2.4% -3.1% -3.4% -3.9% -4.3% -4.6% -4.58%
ROE 3Y Avg snapshot only -55.15%
ROE 5Y Avg snapshot only -6.31%
ROA 3Y Avg snapshot only -39.90%
ROIC Economic snapshot only -41.44%
Cash ROA snapshot only -35.49%
Cash ROIC snapshot only -304.26%
CROIC snapshot only -325.80%
NOPAT Margin snapshot only -4.76%
Pretax Margin snapshot only -5.79%
R&D / Revenue snapshot only 4.29%
SGA / Revenue snapshot only 2.61%
SBC / Revenue snapshot only 79.90%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -9.68 -87.63 -18.39 -10.21 -5.38 -3.27 -4.59 -4.44 -3.99 -6.01 -10.42 -8.20 -8.33 -7.42 -6.44 -7.39 -8.61 -10.18 -6.53 -7.33 -4.732
P/S Ratio 22.16 13.19 8.27 6.65 6.42 4.52 7.89 7.38 4.63 8.30 20.08 18.56 23.65 22.52 20.82 28.27 38.54 52.09 36.48 42.44 28.352
P/B Ratio 9.78 6.53 5.12 5.04 6.91 6.57 42.00 130.46 34.04 5.33 2.94 3.00 4.13 4.55 4.67 5.24 8.33 4.14 3.26 4.25 2.907
P/FCF -14.87 -8.60 -6.00 -5.60 -5.32 -3.67 -6.02 -5.13 -3.44 -5.95 -13.02 -11.84 -12.18 -10.55 -8.37 -8.93 -10.78 -12.48 -7.88 -8.66 -8.659
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -9.28 184.66 -24.40 -10.92 -5.13 -3.14 -4.94 -4.94 -4.32 -5.61 -8.07 -6.26 -7.06 -6.35 -5.49 -6.42 -8.06 -8.20 -4.78 -5.94 -5.938
EV/Revenue 19.03 10.78 6.53 5.14 5.19 3.78 7.61 7.34 4.16 6.38 13.25 12.27 17.92 17.55 16.23 22.72 33.74 39.44 25.19 32.46 32.462
EV/EBIT -8.99 3941.57 -20.74 -9.96 -4.92 -3.04 -4.81 -4.81 -4.13 -5.37 -7.80 -6.07 -6.89 -6.22 -5.37 -6.30 -7.92 -8.06 -4.70 -5.83 -5.826
EV/FCF -12.77 -7.03 -4.73 -4.33 -4.30 -3.07 -5.80 -5.11 -3.09 -4.57 -8.59 -7.83 -9.23 -8.23 -6.52 -7.18 -9.44 -9.45 -5.44 -6.62 -6.624
Earnings Yield -10.3% -1.1% -5.4% -9.8% -18.6% -30.5% -21.8% -22.5% -25.1% -16.6% -9.6% -12.2% -12.0% -13.5% -15.5% -13.5% -11.6% -9.8% -15.3% -13.6% -13.65%
FCF Yield -6.7% -11.6% -16.7% -17.9% -18.8% -27.2% -16.6% -19.5% -29.1% -16.8% -7.7% -8.4% -8.2% -9.5% -12.0% -11.2% -9.3% -8.0% -12.7% -11.5% -11.55%
PEG Ratio snapshot only 0.417
Price/Tangible Book snapshot only 4.248
EV/Gross Profit snapshot only 37.264
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 8.11 7.26 7.29 6.14 4.98 4.13 3.61 3.11 4.03 6.66 21.39 16.64 13.01 10.66 10.22 10.09 7.85 15.39 14.81 13.11 13.105
Quick Ratio 8.06 7.22 7.23 6.08 4.92 4.07 3.53 3.04 3.96 6.59 21.29 16.55 12.94 10.59 10.14 10.02 7.78 15.32 14.73 13.03 13.027
Debt/Equity 0.67 0.67 0.74 0.90 1.29 1.82 6.65 20.98 10.57 0.92 0.18 0.20 0.21 0.24 0.29 0.25 0.30 0.12 0.14 0.15 0.153
Net Debt/Equity -1.38 -1.20 -1.08 -1.14 -1.32 -1.07 -1.48 -0.60 -3.51 -1.23 -1.00 -1.02 -1.00 -1.00 -1.03 -1.03 -1.04 -1.00 -1.01 -1.00 -0.998
Debt/Assets 0.27 0.29 0.32 0.34 0.38 0.43 0.50 0.53 0.51 0.33 0.14 0.14 0.15 0.17 0.19 0.17 0.19 0.10 0.11 0.12 0.118
Debt/EBITDA -0.74 23.22 -4.48 -2.53 -1.19 -1.04 -0.81 -0.80 -1.50 -1.26 -0.76 -0.63 -0.48 -0.43 -0.43 -0.38 -0.33 -0.32 -0.29 -0.28 -0.279
Net Debt/EBITDA 1.52 -41.41 6.53 3.19 1.22 0.61 0.18 0.02 0.50 1.69 4.16 3.21 2.26 1.80 1.55 1.57 1.15 2.63 2.14 1.82 1.825
Interest Coverage -12.15 0.02 -2.33 -3.84 -7.66 -9.12 -11.49 -11.26 -6.42 -6.12 -7.46 -8.33 -10.92 -13.25 -14.40 -16.58 -19.62 -21.47 -23.98 -25.44 -25.436
Equity Multiplier 2.49 2.33 2.35 2.63 3.43 4.22 13.24 39.70 20.68 2.77 1.32 1.37 1.39 1.45 1.53 1.48 1.59 1.23 1.26 1.29 1.291
Cash Ratio snapshot only 12.174
Debt Service Coverage snapshot only -24.958
Cash to Debt snapshot only 7.541
FCF to Debt snapshot only -3.214
Defensive Interval snapshot only 639.0 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.24 0.19 0.23 0.25 0.26 0.29 0.33 0.37 0.36 0.29 0.18 0.19 0.19 0.18 0.13 0.12 0.12 0.08 0.09 0.09 0.093
Inventory Turnover 3.35 3.60 3.88 3.73 3.35 2.82 2.46 2.49 2.58 2.47 2.23 2.36 2.48 2.11 1.90 2.15 2.11 1.99 1.90 1.95 1.954
Receivables Turnover 2.82 2.61 2.68 2.55 2.53 2.43 2.33 2.28 2.66 2.46 2.51 2.12 2.28 2.18 2.30 1.87 1.83 1.65 2.10 1.72 1.716
Payables Turnover 1.06 1.21 1.27 1.29 0.97 0.93 1.01 1.27 1.06 1.11 0.91 1.54 1.45 1.31 1.00 1.25 1.21 1.58 1.05 1.04 1.041
DSO 129 140 136 143 144 150 157 160 137 148 145 172 160 168 158 195 200 221 174 213 212.7 days
DIO 109 102 94 98 109 130 148 147 141 148 164 155 147 173 192 170 173 183 193 187 186.8 days
DPO 343 302 287 284 376 391 363 288 346 329 402 237 252 278 364 291 302 231 348 351 350.6 days
Cash Conversion Cycle -105 -61 -57 -43 -123 -110 -58 18 -67 -32 -93 90 55 63 -13 74 71 174 19 49 48.9 days
Fixed Asset Turnover snapshot only 2.059
Operating Cycle snapshot only 399.5 days
Cash Velocity snapshot only 0.087
Capital Intensity snapshot only 12.897
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 2.1% 1.5% 1.2% 54.6% 29.0% 18.3% 4.7% 9.4% 16.1% 13.5% 15.8% 11.9% 6.5% 9.0% -0.3% -7.3% -9.2% -18.5% -12.8% -8.1% -8.14%
Net Income 8.0% 95.8% 83.0% 68.4% 32.8% -9.8% -3.0% -1.8% -13.0% -13.7% -29.8% -52.5% -1.6% -1.4% -67.2% -56.7% -43.2% -37.4% -50.7% -39.1% -39.08%
EPS 26.0% 96.4% 82.1% 68.6% 25.4% -9.8% -3.3% -2.0% -2.2% 13.5% 23.9% 28.2% -32.6% -55.2% -30.3% -50.5% -30.0% -3.6% -13.9% -6.7% -6.71%
FCF 15.5% -22.7% -29.0% -2.1% -4.4% 5.1% 0.5% -32.4% -29.5% -28.7% -36.1% -22.0% -53.5% -66.8% -60.8% -87.3% -67.2% -59.5% -62.3% -42.2% -42.22%
EBITDA 8.5% 1.0% 89.1% 74.9% 36.4% -25.4% -5.0% -2.5% -10.4% -7.3% -23.3% -47.6% -1.8% -1.7% -79.5% -67.3% -49.8% -41.8% -55.5% -41.9% -41.94%
Op. Income -6.3% -24.2% -13.8% -9.5% -4.1% -0.8% -10.2% -11.5% -5.6% -4.7% -9.7% -36.2% -72.9% -1.1% -1.2% -99.3% -77.6% -57.2% -46.7% -37.6% -37.60%
OCF Growth snapshot only -35.44%
Asset Growth snapshot only 48.74%
Equity Growth snapshot only 69.99%
Debt Growth snapshot only 3.18%
Shares Change snapshot only 30.34%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 1.7% 1.8% 1.8% 1.9% 1.7% 1.3% 1.0% 95.9% 67.4% 49.8% 39.3% 23.7% 16.8% 13.6% 6.5% 4.3% 3.9% 0.3% 0.2% -1.6% -1.58%
Revenue 5Y 84.3% 87.3% 91.8% 92.2% 91.2% 93.0% 96.0% 93.8% 96.4% 96.6% 94.6% 95.4% 90.1% 72.0% 56.5% 50.8% 35.3% 24.4% 18.6% 10.0% 10.02%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y 1.8% 1.9% 2.0% 2.3% 2.7% 1.9% 1.4% 1.2% 73.7% 51.4% 39.7% 23.9% 17.2% 14.1% 6.7% 4.0% 3.2% -1.1% -1.3% -3.2% -3.20%
Gross Profit 5Y 89.8% 93.4% 98.5% 99.0% 98.2% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.1% 1.3% 98.1% 74.7% 61.1% 37.5% 24.3% 17.8% 9.2% 9.23%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 45.8% 41.0% 22.7% 24.5% 21.4% 23.8% 20.8% 4.5% 18.2% -1.3% 30.4% 30.9% 31.1% 30.7% 29.3% 37.6% 37.3% 75.6% 78.6% 76.3% 76.28%
Assets 5Y 21.5% 22.3% 15.6% 16.8% 19.7% 21.9% 10.9% 11.7% 18.2% 28.1% 39.6% 41.9% 40.8% 42.2% 41.0% 33.3% 33.1% 25.3% 24.7% 23.8% 23.82%
Equity 3Y 24.3% 34.9% 46.0% 99.7% 59.9% — — -16.7% — 6.2% 69.8% 67.6% 59.1% 53.0% 49.4% 66.9% 77.4% 1.6% 2.9% 4.5% 4.52%
Book Value 3Y -4.3% 7.0% 18.5% 60.6% 41.0% — — -24.8% — -8.1% 47.9% 32.6% 27.3% 20.7% 17.5% 30.5% 32.7% 90.1% 1.7% 2.9% 2.88%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.59 0.65 0.69 0.75 0.80 0.84 0.86 0.90 0.94 0.95 0.94 0.95 0.93 0.91 0.83 0.77 0.75 0.65 0.63 0.50 0.499
Earnings Stability 0.84 0.01 0.02 0.01 0.10 0.00 0.01 0.01 0.00 0.01 0.04 0.11 0.22 0.09 0.25 0.41 0.55 0.41 0.60 0.77 0.771
Margin Stability 0.71 0.76 0.80 0.80 0.69 0.75 0.79 0.85 0.92 0.93 0.93 0.82 0.69 0.75 0.79 0.86 0.96 0.98 0.98 0.98 0.981
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.97 0.50 0.50 0.50 0.87 0.50 0.50 0.50 0.95 0.95 0.88 0.50 0.50 0.50 0.50 0.50 0.83 0.85 0.50 0.84 0.844
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — 9.77 — -0.95 -8.22 -28.50 -7.39 0.16 4.43 14.58 4.42 0.83 3.99 14.17 3.55 0.34 0.00 -0.04 -0.042
Gross Margin Trend 0.31 0.23 0.19 0.13 0.05 0.02 0.01 0.01 0.01 0.00 0.00 -0.00 -0.00 0.00 -0.01 -0.02 -0.02 -0.04 -0.04 -0.03 -0.030
FCF Margin Trend 16.19 9.47 6.02 4.81 2.30 1.10 0.57 0.06 0.00 -0.01 -0.20 -0.25 -0.66 -0.82 -1.06 -1.66 -1.93 -2.41 -2.61 -2.53 -2.534
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.64 10.00 3.01 1.77 0.97 0.84 0.69 0.77 1.04 0.93 0.78 0.68 0.68 0.70 0.75 0.81 0.76 0.77 0.78 0.79 0.790
FCF/OCF 1.01 1.02 1.02 1.03 1.04 1.06 1.11 1.12 1.11 1.08 1.03 1.02 1.01 1.01 1.02 1.02 1.05 1.06 1.07 1.07 1.071
FCF/Net Income snapshot only 0.846
CapEx/Revenue 2.1% 2.7% 2.7% 3.4% 4.4% 7.2% 13.2% 15.2% 13.5% 10.4% 5.0% 2.8% 2.5% 2.0% 5.0% 6.1% 16.8% 23.1% 28.3% 32.4% 32.39%
CapEx/Depreciation snapshot only 3.092
Accruals Ratio -0.20 0.25 0.21 0.12 -0.01 -0.06 -0.18 -0.14 0.02 -0.03 -0.08 -0.14 -0.17 -0.17 -0.10 -0.08 -0.13 -0.10 -0.11 -0.11 -0.113
Sloan Accruals snapshot only 0.355
Cash Flow Adequacy snapshot only -14.130
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -18.9% -0.1% -0.2% -0.2% -0.2% 0.0% 0.0% -2.2% -3.6% -24.2% -36.1% -37.5% -29.2% -22.1% -0.1% -6.1% -5.1% -20.6% -29.4% -20.9% -20.94%
Total Shareholder Return -18.9% -0.1% -0.2% -0.2% -0.2% 0.0% 0.0% -2.2% -3.6% -24.2% -36.1% -37.5% -29.2% -22.1% -0.1% -6.1% -5.1% -20.6% -29.4% -20.9% -20.94%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.08 -55.07 1.43 1.26 1.13 1.11 1.09 1.09 1.16 1.16 1.13 1.12 1.09 1.08 1.07 1.06 1.05 1.05 1.04 1.04 1.039
EBIT Margin -2.12 0.00 -0.31 -0.52 -1.06 -1.24 -1.58 -1.53 -1.01 -1.19 -1.70 -2.02 -2.60 -2.82 -3.02 -3.61 -4.26 -4.89 -5.36 -5.57 -5.572
Asset Turnover 0.24 0.19 0.23 0.25 0.26 0.29 0.33 0.37 0.36 0.29 0.18 0.19 0.19 0.18 0.13 0.12 0.12 0.08 0.09 0.09 0.093
Equity Multiplier 3.80 2.84 2.64 2.76 2.82 2.87 3.53 4.29 5.93 3.17 1.60 1.68 1.81 1.75 1.40 1.42 1.48 1.31 1.34 1.36 1.359
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.03 $-0.08 $-0.27 $-0.39 $-0.77 $-0.86 $-1.15 $-1.16 $-0.79 $-0.74 $-0.87 $-0.83 $-1.04 $-1.15 $-1.14 $-1.26 $-1.36 $-1.19 $-1.30 $-1.34 $-1.34
Book Value/Share $1.02 $1.07 $0.97 $0.80 $0.60 $0.43 $0.13 $0.04 $0.09 $0.84 $3.09 $2.28 $2.11 $1.88 $1.57 $1.77 $1.40 $2.94 $2.60 $2.31 $2.31
Tangible Book/Share $1.02 $1.07 $0.97 $0.80 $0.60 $0.43 $0.13 $0.04 $0.09 $0.84 $3.09 $2.28 $2.11 $1.88 $1.57 $1.77 $1.40 $2.94 $2.60 $2.31 $2.31
Revenue/Share $0.45 $0.53 $0.60 $0.60 $0.65 $0.62 $0.67 $0.70 $0.68 $0.54 $0.45 $0.37 $0.37 $0.38 $0.35 $0.33 $0.30 $0.23 $0.23 $0.23 $0.23
FCF/Share $-0.67 $-0.81 $-0.83 $-0.72 $-0.78 $-0.76 $-0.88 $-1.01 $-0.91 $-0.75 $-0.70 $-0.58 $-0.71 $-0.81 $-0.88 $-1.04 $-1.08 $-0.97 $-1.08 $-1.13 $-1.13
OCF/Share $-0.66 $-0.80 $-0.81 $-0.70 $-0.75 $-0.72 $-0.79 $-0.90 $-0.82 $-0.69 $-0.68 $-0.57 $-0.70 $-0.80 $-0.86 $-1.02 $-1.03 $-0.92 $-1.01 $-1.06 $-1.06
Cash/Share $2.10 $1.99 $1.76 $1.63 $1.57 $1.24 $1.02 $0.85 $1.30 $1.80 $3.66 $2.77 $2.56 $2.33 $2.06 $2.27 $1.87 $3.31 $2.98 $2.66 $2.66
EBITDA/Share $-0.93 $0.03 $-0.16 $-0.28 $-0.65 $-0.75 $-1.03 $-1.04 $-0.65 $-0.61 $-0.74 $-0.72 $-0.93 $-1.05 $-1.04 $-1.16 $-1.27 $-1.12 $-1.22 $-1.27 $-1.27
Debt/Share $0.69 $0.72 $0.72 $0.72 $0.78 $0.78 $0.83 $0.83 $0.98 $0.77 $0.56 $0.45 $0.45 $0.45 $0.45 $0.45 $0.42 $0.36 $0.35 $0.35 $0.35
Net Debt/Share $-1.41 $-1.28 $-1.04 $-0.91 $-0.80 $-0.46 $-0.19 $-0.02 $-0.32 $-1.03 $-3.09 $-2.32 $-2.11 $-1.88 $-1.61 $-1.82 $-1.46 $-2.95 $-2.62 $-2.31 $-2.31
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 5.715
Altman Z-Prime snapshot only 11.815
Piotroski F-Score 5 3 4 2 5 3 4 4 1 4 5 4 3 4 2 1 1 4 3 3 3
Beneish M-Score -1.98 -0.44 -0.63 -1.69 -2.51 -2.80 -3.58 -2.93 -2.18 -2.40 -2.57 -2.92 -2.87 -2.97 -3.07 -2.84 -3.17 -2.93 -2.99 -3.02 -3.017
Ohlson O-Score snapshot only -5.179
ROIC (Greenblatt) snapshot only -46.74%
Net-Net WC snapshot only $2.19
EVA snapshot only $-248064830.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB+
Credit Score 32.53 25.50 28.46 28.90 27.63 26.64 22.54 22.62 22.95 29.88 65.06 58.59 63.20 57.26 41.71 57.39 60.41 64.89 64.86 64.56 64.555
Credit Grade snapshot only 8
Credit Trend snapshot only 7.170
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 62
Sector Credit Rank snapshot only 57

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms